These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33514507)

  • 21. Human papillomavirus vaccination and all-cause morbidity in adolescent girls: a cohort study of absence from school due to illness.
    Hviid A; Thorsen NM; Thomsen LN; Møller FT; Wiwe A; Frisch M; Valentiner-Branth P; Rytter D; Mølbak K
    Int J Epidemiol; 2021 May; 50(2):518-526. PubMed ID: 33547468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia.
    Maldonado I; Rodríguez Niño N; Valencia CF; Ortiz D; Ayala N; D'silva L; Castro Villarreal S; Salazar D; Lozano C; Angulo D
    Vaccine; 2024 Apr; 42(9):2414-2420. PubMed ID: 38458869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.
    Hofstetter AM; Ompad DC; Stockwell MS; Rosenthal SL; Soren K
    JAMA Pediatr; 2016 May; 170(5):445-52. PubMed ID: 26974250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the human papillomavirus vaccine on the risk of genital warts: a nationwide cohort study of Korean adolescent girls.
    Cho J; Kim EM; Kim J; Shin JY; Kim EH; Park JH; Kwon SL; Kwon GY; Shin SA; Kim J
    Epidemiol Health; 2024; 46():e2024040. PubMed ID: 38549356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study.
    Krogsgaard LW; Vestergaard CH; Plana-Ripoll O; Lützen TH; Vestergaard M; Fenger-Grøn M; Bech BH; Rytter D
    PLoS One; 2017; 12(9):e0184658. PubMed ID: 28886180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.
    Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
    BMC Public Health; 2016 Aug; 15():708. PubMed ID: 27488178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9-18 years: A time-varying cohort study.
    Castillo-Cano B; Martín-Pérez M; Llorente-García A; Montero-Corominas D; Comas-Cufí M; Martín-Merino E
    Vaccine; 2022 Aug; 40(33):4816-4826. PubMed ID: 35792023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.
    Grönlund O; Herweijer E; Sundström K; Arnheim-Dahlström L
    J Intern Med; 2016 Dec; 280(6):618-626. PubMed ID: 27478093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
    Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
    Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Status of HPV vaccination among HPV-infected women aged 20-60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study.
    Seong J; Ryou S; Yoo M; Lee J; Kim K; Jee Y; Cho CH; Kim SM; Hong SR; Jeong DH; Lee WC; Park JS; Kim TJ; Kee MK
    J Gynecol Oncol; 2020 Jan; 31(1):e4. PubMed ID: 31788994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital Records of Pain, Fatigue, or Circulatory Symptoms in Girls Exposed to Human Papillomavirus Vaccination: Cohort, Self-Controlled Case Series, and Population Time Trend Studies.
    Thomsen RW; Öztürk B; Pedersen L; Nicolaisen SK; Petersen I; Olsen J; Sørensen HT
    Am J Epidemiol; 2020 Apr; 189(4):277-285. PubMed ID: 31899791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4-6-year-old Girls: Results to Month 12 From a Randomized Trial.
    Lin L; Parra MM; Sierra VY; Cespedes AS; Granados MA; Luque A; Damaso S; Castrejon Alba MM; Romano-Mazzotti L; Struyf F
    Pediatr Infect Dis J; 2018 Apr; 37(4):e93-e102. PubMed ID: 29424799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Socioeconomic predictors of referral to a diagnostic centre on suspected adverse events following HPV vaccination.
    Weye N; Fonager K; Lützen T; Rytter D
    Eur J Public Health; 2018 Dec; 28(6):1109-1113. PubMed ID: 29800097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis.
    Hviid A; Thorsen NM; Valentiner-Branth P; Frisch M; Mølbak K
    BMJ; 2020 Sep; 370():m2930. PubMed ID: 32878745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV Vaccination and the Risk of Invasive Cervical Cancer.
    Lei J; Ploner A; Elfström KM; Wang J; Roth A; Fang F; Sundström K; Dillner J; Sparén P
    N Engl J Med; 2020 Oct; 383(14):1340-1348. PubMed ID: 32997908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial.
    Neuzil KM; Canh DG; Thiem VD; Janmohamed A; Huong VM; Tang Y; Diep NT; Tsu V; LaMontagne DS
    JAMA; 2011 Apr; 305(14):1424-31. PubMed ID: 21486975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    Enerly E; Flingtorp R; Christiansen IK; Campbell S; Hansen M; Myklebust TÅ; Weiderpass E; Nygård M
    PLoS One; 2019; 14(10):e0223612. PubMed ID: 31600341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
    Mølbak K; Hansen ND; Valentiner-Branth P
    PLoS One; 2016; 11(9):e0162520. PubMed ID: 27611088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study.
    Kreusch T; Wang J; Sparén P; Sundström K
    BMJ Open; 2018 Oct; 8(10):e024477. PubMed ID: 30282687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.